NM_198428.3:c.310delT

Variant summary

Our verdict is Pathogenic. The variant received 15 ACMG points: 16P and 1B. PVS1PP5_Very_StrongBS2_Supporting

The NM_198428.3(BBS9):​c.310delT​(p.Cys104ValfsTer20) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000366 in 1,584,562 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C104C) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00023 ( 2 hom., cov: 30)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

BBS9
NM_198428.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 4.70

Publications

2 publications found
Variant links:
Genes affected
BBS9 (HGNC:30000): (Bardet-Biedl syndrome 9) This gene is downregulated by parathyroid hormone in osteoblastic cells, and therefore is thought to be involved in parathyroid hormone action in bones. The exact function of this gene has not yet been determined. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2017]
BBS9 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 15 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 7-33155681-CT-C is Pathogenic according to our data. Variant chr7-33155681-CT-C is described in ClinVar as [Pathogenic]. Clinvar id is 462970.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS9NM_198428.3 linkc.310delT p.Cys104ValfsTer20 frameshift_variant Exon 4 of 23 ENST00000242067.11 NP_940820.1 Q3SYG4-1A0A090N8P4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS9ENST00000242067.11 linkc.310delT p.Cys104ValfsTer20 frameshift_variant Exon 4 of 23 1 NM_198428.3 ENSP00000242067.6 Q3SYG4-1

Frequencies

GnomAD3 genomes
AF:
0.000225
AC:
34
AN:
151028
Hom.:
2
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00218
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000725
AC:
18
AN:
248184
AF XY:
0.0000596
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000525
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000167
AC:
24
AN:
1433534
Hom.:
0
Cov.:
28
AF XY:
0.0000168
AC XY:
12
AN XY:
714442
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33044
American (AMR)
AF:
0.000494
AC:
22
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25916
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39252
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85412
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
9.19e-7
AC:
1
AN:
1087848
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000225
AC:
34
AN:
151028
Hom.:
2
Cov.:
30
AF XY:
0.000326
AC XY:
24
AN XY:
73656
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41060
American (AMR)
AF:
0.00218
AC:
33
AN:
15170
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4778
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10386
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67706
Other (OTH)
AF:
0.00
AC:
0
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000212

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Bardet-Biedl syndrome 9 Pathogenic:3
Mar 27, 2024
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 21, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2022
Mendelics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

BBS9-related disorder Pathogenic:1
May 09, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The BBS9 c.310delT variant is predicted to result in a frameshift and premature protein termination (p.Cys104Valfs*20). The c.310del variant has been reported, along with a variant of uncertain significance, in a teenage patient with obesity (Supplementary Table 3, Kleinendorst et al. 2018. PubMed ID: 29970488). This variant was also reported with another BBS9 frameshift variant in a patient with Bardet-Biedl syndrome (reported as c.175del, p.C59fs*20 using the alternative transcript NM_001348042 in K131 in Zacchia et al. 2021. PubMed ID: 33964006). This variant is reported in 0.051% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in BBS9 are expected to be pathogenic for autosomal recessive Bardet-Biedl syndrome (Khan et al. 2016. PubMed ID: 26846096; Supplementary Table 3, Shaheen et al. 2016. PubMed ID: 27894351; OMIM: #615986). This variant is interpreted as likely pathogenic. -

Bardet-Biedl syndrome Pathogenic:1
Aug 01, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Cys104Valfs*20) in the BBS9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BBS9 are known to be pathogenic (PMID: 16380913, 20177705). This variant is present in population databases (rs777498165, gnomAD 0.05%). This premature translational stop signal has been observed in individual(s) with obesity (PMID: 29970488). ClinVar contains an entry for this variant (Variation ID: 462970). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.7
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747388658; hg19: chr7-33195293; API